Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5391-5400 Newer>

The Motley Fool January 28, 2009 Brian Orelli	A Mini-Pfizer in the Making Bristol-Myers Squibb looks like its setting itself up to be the next Pfizer.
Chemistry World January 27, 2009 Matt Wilkinson	Pfizer's Wyeth injection Pfizer has agreed to pay $68 billion ( 48.3 billion) for rival US biopharmaceutical firm Wyeth, gaining access to its rich product portfolio and promising pipeline of experimental drugs.
InternetNews January 27, 2009 Kenneth Corbin	Privacy 'Achilles Heel' in Health IT Debate Senate hearing considers privacy concerns as Congress prepares to spend billions on digitizing healthcare industry.
The Motley Fool January 27, 2009 Brian Orelli	Not All Medical Device Makers Are Hurting While slowdowns in capital spending at hospitals wreaked havoc on other medical-device makers Kinetic Concepts seems to have been able to get through it with only minor bruises.
The Motley Fool January 27, 2009 Devon Rackle	Almost Family Almost Makes the Cut Shares of home health provider Almost Family have risen eightfold in the past five years, but you still might want to stay away for the time being.
The Motley Fool January 27, 2009 Brian Orelli	Testing a Recession-Resistant Hypothesis Quest Diagnostic looks poised for growth even in bad times.
The Motley Fool January 27, 2009 Brian Orelli	Amgen's Anemic Again 2009 won't be stellar, but the future looks better.
The Motley Fool January 27, 2009 Robert Steyer	Another Angle for Fibromyalgia In the past 18 months, the FDA has approved three drugs that can be used to treat the disease. Which pharma companies will benefit?
The Motley Fool January 26, 2009 Brian Orelli	Deja Vu All Over Again There's hardly anything to like about Pfizer's deal to buy Wyeth. This is what got Pfizer into its problem in the first place.
The Motley Fool January 26, 2009 Brian Orelli	Have Drugs, Will Travel After buying Bristol-Myers Squibb's businesses in Egypt and Pakistan, GlaxoSmithKline is now off to Africa.
<Older 5391-5400 Newer> Return to current articles.